× Current Issue Archive Submit Article
Conflicts of Interest Copyright and Access Open access policy Editorial Policies Peer Review Policy Privacy Statement Publishing Ethics Generative AI Usage Policy
Editor in chief Associate Editors Advisory Board International Editors
Contact Us About Us Aim & Scope Abstracting And Indexing Author Guidelines Join As Editor
Views: 1176 Downloads: 80

Selenomethionine in the correction of selenium deficiency: effects on oxidative stress and immune status


, , , , , , ,
  1. Faculty of Pediatrics, Stavropol State Medical University, Stavropol, Russia.
  2. Faculty of Medicine, Stavropol State Medical University, Stavropol, Russia.
  3. Faculty of Medicine and Prevention, Rostov State Medical University, Rostov-on-Don, Russia.

Abstract

Selenium is an essential trace element that plays a key role in antioxidant protection and immune regulation. In this study, the effectiveness of a 12-week intake of selenomethionine (200 mcg /day) for the correction of selenium deficiency and related metabolic disorders was studied. A randomized, double-blind, placebo-controlled trial involved 60 volunteers with baseline plasma selenium levels <70 mcg/l. The primary criteria for evaluating the effectiveness of the intervention were the dynamics of selenium status, indicators of oxidative stress (malondialdehyde and glutathione peroxidase activity), and immunological parameters (IgA, IL-6 levels, and lymphocyte subpopulations). The results of the study showed that taking selenomethionine led to a significant increase in plasma selenium levels by 58.7% (p < 0.001), accompanied by a decrease in malondialdehyde levels by 33% and an increase in glutathione peroxidase activity by 38%. The immunological profile showed a significant increase in the level of secretory IgA (by 30%) and an increase in the number of NK cells (by 24%). A subjective assessment of the quality of life according to the SF-36 questionnaire revealed an improvement in vital signs by 25% and overall well-being by 19%. The data obtained indicate the high efficacy of selenomethionine in the correction of selenium deficiency conditions and related disorders. The results of the study substantiate the expediency of using selenium-containing additives to improve antioxidant protection and immune function, especially in residents of regions with low selenium content in food products.



Keywords: Selenium, Selenomethionine, Oxidative stress, Antioxidant protection, Immune status, Biologically active additives

Introduction  

Selenium is a vital trace element that plays a key role in antioxidant protection, immune regulation, and thyroid hormone metabolism [1]. Despite its need for trace amounts, selenium deficiency remains a global problem, especially in regions with a low content of this element in the soil and, as a result, in food [2, 3]. According to the World Health Organization (WHO), about 1 billion people worldwide are deficient in selenium to one degree or another [4]. In Russia, selenium deficiency is most pronounced in the northwestern and central regions, where soils are poor in this element. According to research by the Institute of Nutrition of the Russian Academy of Medical Sciences, up to 40% of the Russian population consumes selenium below the recommended daily allowance (55-70 micrograms for adults), which creates a predisposition to the development of pathologies associated with its deficiency [5, 6]. Figure 1 shows the scheme of selenium metabolism in the body.

 

 

Figure 1. The scheme of selenium metabolism in the body

 

 

The main reason for insufficient intake of selenium in the body is its low content in the food chain [7]. Selenium accumulates in plants from the soil and then enters the human body through animal and plant products [8]. However, in regions with selenium-depleted soils (for example, in some parts of China, Finland, and Russia), even a balanced diet does not provide sufficient amounts of this trace element [9]. Historically, the most severe forms of selenium deficiency have been recorded in China, where, in Keshan Province in the mid-20th century, a link was found between extremely low selenium levels and the development of cardiomyopathy (Keshan disease) [10-12]. In Russia, the most vulnerable groups are residents of the Northwestern Federal District, Siberia, and the Far East, where the selenium content in soils is 2-3 times lower than in the southern regions [13, 14].

In addition to geochemical factors, selenium deficiency can lead to:

  • Insufficient consumption of selenium-containing products (seafood, Brazil nuts, meat, eggs) [15].
  • Malabsorption in diseases of the gastrointestinal tract (celiac disease, Crohn's disease) [16, 17].
  • Increased selenium consumption in chronic inflammatory processes, pregnancy, and intense physical exertion [18-20].

The effects of selenium deficiency are diverse and affect almost all body systems. The most significant are:

  • Oxidative stress. Selenium is a part of the enzymes glutathione peroxidase (GPx) and thioredoxin reductase (TrxR), which neutralize reactive oxygen species (ROS). With a lack of selenium, the activity of these enzymes decreases, which leads to the accumulation of ROS, damage to lipids (malondialdehyde, MDA), proteins, and DNA [21-23].
  • Violation of the immune response. Selenium modulates the differentiation of T-lymphocytes and the production of cytokines. Its deficiency shifts the balance towards the Th2 response, reducing antiviral and antitumor protection [24].
  • Thyroid gland dysfunction. Selenium is necessary for deiodinases that convert thyroxine (T4) into active triiodothyronine (T3) [25].

Selenium is a key component of selenoproteins that perform antioxidant and immunoregulatory functions [26]. The most studied of them is glutathione peroxidase (GPx), which catalyzes the reduction of hydrogen peroxide and lipid hydroperoxides [27]. With selenium deficiency, GPx activity decreases, which leads to:

  • Increased levels of malonic dialdehyde (MDA), a marker of lipid peroxidation. Studies show that in individuals with low selenium levels, plasma MDA concentrations may be 30-50% higher than normal [28].
  • Accumulation of 8-hydroxydeoxyguanosine (8-OHdG) – an indicator of oxidative DNA damage associated with cancer risk [29, 30].

The effect of selenium on the immune system is realized through several mechanisms:

  • Regulation of the cytokine profile. Selenium contributes to the predominance of the Th1 response (interferon-γ, IL-2), which is critical for combating intracellular pathogens. Deficiency increases the Th2 response (IL-4, IL-6), which increases the risk of allergic and autoimmune reactions [31, 32].
  • Activation of NK cells and phagocytosis. Selenium deficiency reduces the cytotoxic activity of natural killers by 20-40%, which is confirmed by studies on models of viral infections [33, 34].
  • Protection against immunosuppression. Under conditions of oxidative stress, selenium prevents apoptosis of immunocompetent cells, maintaining their functional activity [35, 36].

Since dietary sources of selenium are not always available, biologically active additives (dietary supplements) based on selenomethionine are becoming an effective tool for correcting deficiency [37, 38]. Selenomethionine is an organic form of selenium with high bioavailability (up to 90% compared to 50% for sodium selenite) [39]. Clinical studies demonstrate that taking 100-200 mcg/day of selenomethionine for 8-12 weeks leads to:

  • Normalization of plasma selenium levels (an increase of 40-60%) [40, 41].
  • Reduction of MDA and restoration of GPx activity [40].
  • Improved immune parameters (increased IgA, decreased proinflammatory cytokines) [42].

In Russia, where selenium deficiency is widespread but often remains undiagnosed, the use of dietary supplements can become an important measure to prevent related conditions, from chronic fatigue to increased risk of cardiovascular and autoimmune diseases [43, 44].

The purpose of the study

In this work, we evaluate the effect of a 12-week intake of dietary supplements based on selenomethionine (200 mcg/day) on markers of oxidative stress (MDA, GPx) and immune status (IgA, IL-6, TNF-α) in people with moderate selenium deficiency. The data obtained can serve as a basis for recommendations on the correction of nutritional status in risk groups.

Materials and Methods

The present study is a prospective, randomized, double-blind, placebo-controlled trial aimed at evaluating the effect of selenomethionine in the form of dietary supplements on biochemical and immunological parameters in individuals with moderate selenium deficiency. The study was conducted on the basis of the Stavropol Regional Clinical Diagnostic Center (Stavropol, Russia) in the period from September 2024 to January 2025. The study protocol was approved by the local ethics committee, and all participants provided written informed consent.

The study included 60 volunteers aged 18 to 60 years, divided into two groups: the main group (taking selenomethionine) and the control group (placebo) (Table 1). Inclusion criteria: plasma selenium levels below 70 mcg/L, absence of chronic diseases in the stage of decompensation, absence of intake of selenium-containing supplements during the last 3 months. Exclusion criteria: pregnancy, oncological diseases, severe liver and kidney pathologies.

 

 

Table 1. Demographic and clinical characteristics of participants

Parameter

Group of selenomethionine (n=30)

Placebo group (n=30)

p-value

Age (years)

42.5 ± 8.3

44.1 ± 7.9

0.45

Woman / Man

18 / 12

16 / 14

0.62

Baseline Se level (mcg/L)

58.2 ± 9.1

59.4 ± 8.7

0.61

BMI (kg/m2)

24.7 ± 3.2

25.1 ± 3.5

0.67

 

 

The groups were statistically homogeneous in the main parameters (p > 0.05), which excluded the influence of confounding factors on the results of the study.

The participants in the main group received 200 mcg/day of selenomethionine in capsule form, while the control group took a placebo (microcrystalline cellulose) in an identical package. The duration of admission was 12 weeks. All participants were instructed not to change their usual diet or take other vitamin and mineral supplements during the study.

Methods for estimating parameters

  • Biochemical analyses
  • Selenium levels in blood plasma were determined by inductively coupled plasma mass spectrometry (ICP-MS).
  • Glutathione peroxidase (GPx) activity in red blood cells was measured spectrophotometrically using a commercial reagent kit (specify manufacturer).
  • The concentration of malonic dialdehyde (MDA) was assessed by reaction with thiobarbituric acid (TBK test).

 

  • Immunological studies
  • The level of immunoglobulins (IgA, IgG) and proinflammatory cytokines (IL-6, TNF-α) was determined by enzyme immunoassay (ELISA).
  • Lymphocyte subpopulations (CD4+, CD8+, NK cells) were analyzed using flow cytometry.

 

  • The survey

For a subjective assessment of well-being, participants filled out the SF-36 questionnaire (The Short Form Health Survey), which included questions about energy levels, physical activity, emotional state, and the presence of symptoms (fatigue, headache). The survey was conducted before the start of the study and after 12 weeks of taking dietary supplements.

The data was processed using the SPSS 26.0 program. To compare the groups, the Student's t-test (normal distribution) or the Mann-Whitney criterion (nonparametric data) was used. Correlation analysis was performed using the Pearson coefficient. The level of statistical significance was set at p < 0.05.

Results and Discussion

Dynamics of selenium levels and indicators of oxidative stress

After 12 weeks of taking selenomethionine at a dose of 200 mcg /day, a statistically significant increase in selenium concentration in blood plasma was observed in the main group. The average selenium level increased from 58.2 ± 9.1 mcg/L to 92.4 ± 11.3 mcg/L (p < 0.001), while no changes were recorded in the placebo group (59.4 ± 8.7 mcg/l to 60.1 ± 9.2 mcg/l; p = 0.87). A similar trend was observed when measuring the selenium content in red blood cells: an increase from 125.6 ± 15.2 ng/ml to 178.3 ± 20.1 ng/ml (p < 0.001) in the main group (Table 2).

 

 

Table 2. Dynamics of biochemical parameters in the study groups

Indicator

Selenomethionine group (before/after)

Placebo group (before/after)

p-value

Se in plasma (mcg/L)

58.2±9.1 / 92.4±11.3

59.4±8.7 / 60.1±9.2

<0.001

Se in erythrocytes (ng/ml)

125.6±15.2 / 178.3±20.1

127.8±14.9 / 129.1±15.4

<0.001

GPx activity (U/mg protein)

35.2±4.1 / 48.6±5.3

34.9±3.9 / 35.4±4.2

<0.001

MDA level (nmol/ml)

4.8±0.9 / 3.2±0.7

4.7±0.8 / 4.6±0.9

<0.001

 

 

In parallel with the normalization of selenium status, a significant improvement in oxidative stress indicators was recorded in the main group. The activity of glutathione peroxidase (GPx) increased by 38% (from 35.2 ± 4.1 to 48.6 ± 5.3 U/mg of protein; p < 0.001), whereas no changes were observed in the placebo group. Malondialdehyde Concentration (MDA) as a marker of lipid peroxidation decreased by 33% (from 4.8 ± 0.9 to 3.2 ± 0.7 nmol/ml; p < 0.001).

Effect on immunological parameters

The intake of selenomethionine had a significant modulating effect on the immune system (Table 3). In the main group, there was an increase in the level of secretory IgA in saliva from 45.2 ± 8.1 mg/dl to 58.7 ± 9.3 mg/dl (p < 0.01), which indicates increased mucosal immunity. The concentration of the proinflammatory cytokine IL-6 decreased from 12.4 ± 2.1 pg/ml to 8.3 ± 1.7 pg/ml (p < 0.01).

 

 

Table 3. Changes in immunological parameters

Parameter

Selenomethionine group (before/after)

Placebo group (before/after)

p-value

IgA (mg/dl)

45.2 ± 8.1 / 58.7 ± 9.3

44.8 ± 7.9 / 45.1 ± 8.2

<0.01

IL-6 (pg/ml)

12.4 ± 2.1 / 8.3 ± 1.7

12.1 ± 2.0 / 11.9 ± 2.1

<0.01

CD4+/CD8+

1.8 ± 0.3 / 2.1 ± 0.4

1.7 ± 0.3 / 1.8 ± 0.3

0.03

NK cells (%)

14.2 ± 2.1 / 17.6 ± 2.5

14.0 ± 2.0 / 14.3 ± 2.2

<0.01

 

 

Of particular interest are changes in lymphocyte subpopulations. The proportion of NK cells (CD56+) increased from 14.2 ± 2.1% to 17.6 ± 2.5% (p < 0.01), indicating an increased antitumor and antiviral immune response. The ratio of CD4+/CD8+ lymphocytes also changed towards optimal values (from 1.8 ± 0.3 to 2.1 ± 0.4; p = 0.03).

Results of the quality of life survey

Analysis of the SF-36 questionnaire data revealed a significant improvement in quality of life in the main group (Table 4). The biggest changes affected the scales of "Vital activity" (an increase of 25%, p < 0.01) and "General health" (an improvement of 19%, p < 0.05). Participants noted a decrease in fatigue and an increase in performance after 6 weeks of taking the supplement.

 

 

Table 4. Quality of life indicators according to the SF-36 questionnaire

Criteria

Selenomethionine group (before/after)

Placebo group (before/after)

p-value

Physical functioning

65.2 ± 8.1 / 73.4 ± 7.9

64.8 ± 7.9 / 65.1 ± 8.2

<0.05

The role of physical problems

58.3 ± 9.2 / 68.7 ± 8.5

57.9 ± 9.0 / 58.2 ± 9.3

<0.05

Vital activity

45.1 ± 7.3 / 56.4 ± 6.8

44.8 ± 7.1 / 45.3 ± 7.4

<0.01

General health status

60.4 ± 7.5 / 71.9 ± 6.7

60.1 ± 7.3 / 60.7 ± 7.6

<0.05

 

 

Correlation analysis

A strong negative correlation was found between plasma selenium levels and MDA concentrations (r = -0.72, p < 0.001), as well as a positive correlation between GPx activity and IgA content (r = 0.65, p < 0.01). These findings confirm the relationship between selenium status, antioxidant protection, and immune function.

Side effects

No serious adverse events were reported during the study. Two participants in the main group (6.7%) had mild dyspeptic symptoms (nausea), which did not require drug withdrawal. No side effects were detected in the placebo group.

Thus, a 12-week intake of selenomethionine at a dose of 200 mcg/day led to a significant improvement in selenium status, a decrease in oxidative stress, and normalization of immunological parameters in individuals with initial selenium deficiency. The results obtained confirm the expediency of using selenium-containing additives to correct the identified disorders.

The data obtained in our study demonstrate the significant effectiveness of a 12-week intake of selenomethionine at a dose of 200 mcg/day for the correction of selenium deficiency and related metabolic disorders. Our results are consistent with current understanding of the role of selenium in maintaining redox homeostasis and immune regulation, which has been confirmed in recent studies [45-48].

The main achievement of the study was the confirmation of the hypothesis that the replenishment of selenium deficiency leads to a statistically significant decrease in markers of oxidative stress.

The 33% decrease in the concentration of malonic dialdehyde (MDA) that we recorded is fully correlated with the data from other studies [49, 50]. The authors showed that taking 100-200 micrograms of selenium per day for 3-6 months reduces the level of MDA by an average of 27-38%, depending on the initial selenium status. It is especially important that our study demonstrated a strong negative correlation (r = -0.72) between plasma selenium levels and MDA concentrations, which confirms the key role of this trace element in antioxidant protection.

The observed 38% increase in glutathione peroxidase (GPx) activity is of particular interest in the context of the work of other researchers. It was found that GPx activity is the most sensitive indicator of the adequacy of selenium status, and its recovery occurs faster when taking selenomethionine than when using inorganic forms of selenium [51-53]. This explains the pronounced antioxidant effect registered in our study after 12 weeks of intervention.

The results concerning the immunomodulatory effect of selenium are convincingly confirmed in modern immunological studies. The 30% increase in the level of secretory IgA that we found is consistent with the data of scientists who demonstrated that selenium promotes the differentiation of B lymphocytes into IgA-producing cells in intestinal Peyer plaques [54, 55]. A 24% increase in the number of NK cells corresponds to the results of another study, which showed that selenomethionine enhances the expression of activation receptors (NKG2D) on the surface of natural killers [56, 57].

Our 33% reduction in IL-6 levels deserves special attention, which is of great clinical importance. These data are consistent with the results of a large cohort study that included 5,642 participants and established an inverse relationship between the level of selenium in the blood and the concentration of proinflammatory cytokines. The authors suggested that this effect is mediated by the ability of selenium to suppress the activation of NF-kB, a key regulator of the inflammatory response [58, 59].

The improvement in quality of life recorded using the SF-36 questionnaire is consistent with the observations of the authors, who noted the positive effect of selenium on energy metabolism and cognitive functions [60, 61]. An increase of 25% on the scale of "Vital activity" is especially significant, which may be associated with an improvement in thyroid function against the background of normalization of selenium status [62, 63].

Some aspects of our research require special discussion. First, the optimal dosage of selenomethionine remains a subject of scientific debate. If our data confirms the effectiveness of 200 mcg/day, then another study showed that a dose of 100 mcg/day may be sufficient for people with moderate deficiency [59, 64]. This issue requires further study within the framework of an individual-oriented approach to nutritional support.

Secondly, an important limitation of our study was the relatively short follow-up period (12 weeks). Long-term studies have shown that the maximum effect of selenomethionine on the immune system can develop within 6-9 months of continuous administration [65-68]. This indicates the need for longer clinical trials.

The practical significance of our study is to substantiate the use of selenomethionine for the correction of selenium deficiency conditions, especially in regions with low selenium content in soils. The data obtained can be used to develop clinical recommendations on nutritional support for patients with increased oxidative stress and immune disorders.

In conclusion, it should be noted that our results make a significant contribution to understanding the physiological role of selenium and confirm the expediency of its use in clinical practice. They are consistent with current international research and emphasize the importance of maintaining an adequate selenium status for human health.

Conclusion

The conducted study has convincingly demonstrated the effectiveness of the use of selenomethionine for the correction of selenium deficiency and related metabolic disorders. A twelve-week course of taking the supplement at a dose of 200 mcg/day led to a significant improvement in selenium status, which is confirmed by an increase in selenium concentration in blood plasma by more than 50%. At the same time, there was a marked decrease in markers of oxidative stress and an increase in the activity of key antioxidant enzymes.

An important result of the study was the identification of a significant effect of selenomethionine on immune function. The recorded increase in the level of secretory immunoglobulin A and activation of cellular immunity indicate the complex immunomodulatory effect of selenium. These changes were accompanied by significant improvements in subjective health indicators, including improved vitality and overall performance of participants.

The data obtained are of significant practical importance for the prevention and correction of conditions associated with selenium deficiency. The results are particularly relevant for residents of regions with low selenium content in the soil and, consequently, in food products. Regular intake of selenomethionine in physiological doses can be considered an effective strategy for maintaining antioxidant protection and immune resistance of the body.

Promising areas of further research include the study of the long-term effects of selenium supplementation, optimizing dosages taking into account individual metabolic characteristics, as well as evaluating the effect of selenium on intestinal microbiocenosis and epigenetic regulation. Special attention should be paid to the development of personalized approaches to the use of selenium-containing supplements in various clinical and preventive situations.

The results of the work make a significant contribution to understanding the physiological role of selenium and substantiate the expediency of its use to improve health indicators in people with moderate deficiency of this essential trace element. The data obtained can serve as a scientific basis for the development of practical recommendations on nutritional support for various groups of the population.

Acknowledgments: The authors would like to thank all participants involved in this study. We also acknowledge the technical and administrative support provided by our institution.

Conflict of interest: None

Financial support: None

Ethics statement: The study was conducted in accordance with ethical standards and approved by the relevant institutional review board. Informed consent was obtained from all participants, where applicable.

References

  1. Mojadadi A, Au A, Salah W, Witting P, Ahmad G. Role for Selenium in metabolic homeostasis and human reproduction. Nutrients. 2021;13(9):3256. doi:10.3390/nu13093256
  2. Gać P, Czerwińska K, Macek P, Jaremków A, Mazur G, Pawlas K, et al. The importance of Selenium and Zinc deficiency in cardiovascular disorders. Environ Toxicol Pharmacol. 2021;82:103553. doi:10.1016/j.etap.2020.103553
  3. Wang S, Liu X, Lei L, Wang D, Liu Y. Selenium deficiency induces apoptosis, mitochondrial dynamic imbalance, and inflammatory responses in calf liver. Biol Trace Elem Res. 2022;200(11):4678-89. doi:10.1007/s12011-021-03059-5
  4. Bakaloudi DR, Halloran A, Rippin HL, Oikonomidou AC, Dardavesis TI, Williams J, et al. Intake and adequacy of the vegan diet. A systematic review of the evidence. Clin Nutr. 2021;40(5):3503-21. doi:10.1016/j.clnu.2020.11.035
  5. Kolmykova LI, Korobova EM, Baranchukov VS, Kurnosova IV, Silenok AV, Makarova EM. Chemical composition of groundwater used for drinking in conditions of natural deficiency of Iodine and Selenium and evaluation of its health effect: the case of Bryansk region (Russia). Environ Geochem Health. 2021;43(12):4987-5009. doi:10.1007/s10653-021-01022-w
  6. Dabravolski SA, Sukhorukov VN, Melnichenko AA, Khotina VA, Orekhov AN. The role of Selenium in atherosclerosis development, progression, prevention, and treatment. Biomedicines. 2023;11(7):2010. doi:10.3390/biomedicines11072010
  7. Blinov A, Nagdalian A, Serov A, Blinova A, Rekhman Z, Gvozdenko A, et al. Selenium nanoparticles stabilized with Tween 80: Synthesis, characterization, and application in fortified milk and fermented dairy products. Colloids Surf A Physicochem Eng Asp. 2025;706:135822. doi:10.1016/j.colsurfa.2024.135822
  8. Koekkoek KWA, Berger MM. An update on essential micronutrients in critical illness. Curr Opin Crit Care. 2023;29(4):315-29. doi:10.1097/MCC.0000000000001062
  9. Kieliszek M. Selenium. Adv Food Nutr Res. 2021;96:417-29. doi:10.1016/bs.afnr.2021.02.019
  10. Fabian D, Ahmed I. Keshan disease [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan– [cited 2025 Jul 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537173/
  11. Shimada BK, Alfulaij N, Seale LA. The impact of Selenium deficiency on cardiovascular function. Int J Mol Sci. 2021;22(19):10713. doi:10.3390/ijms221910713
  12. Souza LSL, Campos RO, Braga JS Filho, Jesus JDS, Ramos HE, Anunciação SM, et al. Selenium nutritional status and thyroid dysfunction. Arch Endocrinol Metab. 2025;69(1):e230348. doi:10.20945/2359-4292-2023-0348
  13. Troshina EA, Senyushkina ES, Ioutsi VA, Nikankina LV. The study of blood serum trace elements in comparison with the structural and functional characteristics of goiter and the carriage of antithyroid antibodies in some regions of Russia. Vopr Pitan. 2022;91(6):85-91. [In Russian]. doi:10.33029/0042-8833-2022-91-6-85-91
  14. Varlamova EG, Turovsky EA, Blinova EV. Therapeutic potential and main methods of obtaining Selenium nanoparticles. Int J Mol Sci. 2021;22(19):10808. doi:10.3390/ijms221910808
  15. Veisa V, Kalere I, Zake T, Strele I, Makrecka-Kuka M, Upmale-Engela S, et al. Assessment of Iodine and Selenium nutritional status in women of reproductive age in Latvia. Medicina (Kaunas). 2021;57(11):1211. doi:10.3390/medicina57111211
  16. Wu X, Qian L, Liu K, Wu J, Shan Z. Gastrointestinal microbiome and gluten in celiac disease. Ann Med. 2021;53(1):1797-805. doi:10.1080/07853890.2021.1990392
  17. Caparrós E, Wiest R, Scharl M, Rogler G, Gutiérrez Casbas A, Yilmaz B, et al. Dysbiotic microbiota interactions in Crohn's disease. Gut Microbes. 2021;13(1):1949096. doi:10.1080/19490976.2021.1949096
  18. Bjørklund G, Shanaida M, Lysiuk R, Antonyak H, Klishch I, Shanaida V, et al. Selenium: An Antioxidant with a Critical Role in Anti-Aging. Molecules. 2022;27(19):6613. doi:10.3390/molecules27196613
  19. Atazadegan MA, Heidari-Beni M, Riahi R, Kelishadi R. Association of Selenium, Zinc, and Copper concentrations during pregnancy with birth weight: a systematic review and meta-analysis. J Trace Elem Med Biol. 2022;69:126903. doi:10.1016/j.jtemb.2021.126903
  20. Demircan K, Chillon TS, Jensen RC, Jensen TK, Sun Q, Bonnema SJ, et al. Maternal Selenium deficiency during pregnancy in association with autism and ADHD traits in children: the odense child cohort. Free Radic Biol Med. 2024;220:324-32. doi:10.1016/j.freeradbiomed.2024.05.001
  21. Bizerea-Moga TO, Pitulice L, Bizerea-Spiridon O, Moga TV. Exploring the link between oxidative stress, Selenium levels, and obesity in youth. Int J Mol Sci. 2024;25(13):7276. doi:10.3390/ijms25137276
  22. Soares de Oliveira AR, Cruz JC, Morais BS, Dos Santos RL, Melo RS, Fontenelle LC, et al. Selenium status and oxidative stress in obese: influence of adiposity. Eur J Clin Invest. 2021;51(9):e13538. doi:10.1111/eci.13538
  23. Skesters A, Kustovs D, Lece A, Moreino E, Petrosina E, Rainsford KD. Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery. Inflammopharmacology. 2022;30(2):499-503. doi:10.1007/s10787-022-00925-z
  24. Vaivode I, Zake T, Strele I, Upmale-Engela S, Gogins D, Gersone G, et al. Stress-related immune response and Selenium status in autoimmune thyroid disease patients. Int J Mol Sci. 2023;24(3):2440. doi:10.3390/ijms24032440
  25. Verevkina M, Goncharov V, Nesmeyanov E, Kamalova O, Baklanov I, Pokhilko A, et al. Application of the Se NPs-Chitosan molecular complex for the correction of Selenium deficiency in a rat model. Potravinarstvo Slovak J Food Sci. 2023;17:455–66. doi:10.5219/1871
  26. Blinov AV, Maglakelidze DG, Rekhman ZA, Yasnaya MA, Gvozdenko AA, Golik AB, et al. Investigation of the effect of dispersion medium parameters on the aggregative stability of Selenium nanoparticles stabilized with Catamine AB. Micromachines. 2023;14:433. doi:10.3390/mi14020433
  27. Pei J, Pan X, Wei G, Hua Y. Research progress of glutathione peroxidase family (GPX) in redoxidation. Front Pharmacol. 2023;14:1147414. doi:10.3389/fphar.2023.1147414
  28. Li Y, He Q, He CY, Cai C, Chen Z, Duan JZ. Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis. ESC Heart Fail. 2023;10(4):2510-23. doi:10.1002/ehf2.14404
  29. Kakehashi A, Suzuki S, Ishii N, Okuno T, Kuwae Y, Fujioka M, et al. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and glucose metabolites by liver tumor cells are the important characteristic features of metabolic syndrome and non-alcoholic steatohepatitis-associated hepatocarcinogenesis. Int J Mol Sci. 2020;21(20):7746. doi:10.3390/ijms21207746
  30. Watanabe S, Masamura N, Satoh S, Hirao T. Evaluating the effectiveness of DNA barcoding for insect identification: a comprehensive review. Entomol Lett. 2024;4(2):34-41. doi:10.51847/ZVNniNFsOR
  31. Kryczyk-Kozioł J, Prochownik E, Błażewska-Gruszczyk A, Słowiaczek M, Sun Q, Schomburg L, et al. Assessment of the effect of Selenium supplementation on production of selected cytokines in women with Hashimoto's thyroiditis. Nutrients. 2022;14(14):2869. doi:10.3390/nu14142869
  32. Patil RD. Structural Insights into the alimentary canal of Deudorix isocrates (Fab.) Larvae (Lepidoptera: Lycaenidae). Entomol Lett. 2022;2(1):28-36. doi:10.51847/PoTmk4aq6W
  33. Chen W, Liu Z, Zheng Y, Wei B, Shi J, Shao B, et al. Selenium donor restricts the intracellular growth of Mycobacterium tuberculosis through the induction of c-Jun-mediated both canonical autophagy and LC3-associated phagocytosis of alveolar macrophages. Microb Pathog. 2021;161(Pt B):105269. doi:10.1016/j.micpath.2021.105269
  34. Dongmo LF, Tamesse JL. Population trends of hilda cameroonensis tamesse & dongmo (tettigometridae), a pest of Vernonia amygdalina Delile in Yaoundé, Cameroon. Int J Vet Res Allied Sci. 2023;3(1):1-10. doi:10.51847/CurzkzD60G
  35. Razaghi A, Poorebrahim M, Sarhan D, Björnstedt M. Selenium stimulates the antitumour immunity: insights to future research. Eur J Cancer. 2021;155:256-67. doi:10.1016/j.ejca.2021.07.013
  36. Fiodorova OA, Sivkova EI, Nikonov AA. Safeguarding beef cattle from gnats and gadflies in the Southern Tyumen Region. Int J Vet Res Allied Sci. 2022;2(2):8-13. doi:10.51847/iVXOeXmSNZ
  37. Jing J, Zeng H, Shao Q, Tang J, Wang L, Jia G, et al. Selenomethionine alleviates environmental heat stress induced hepatic lipid accumulation and glycogen infiltration of broilers via maintaining mitochondrial and endoplasmic reticulum homeostasis. Redox Biol. 2023;67:102912. doi:10.1016/j.redox.2023.102912
  38. Marian M, Shah R, Gashi B, Zhang S, Bhavnani K, Wartzack S, et al. The role of synovial fluid morphology in joint lubrication and function. Int J Vet Res Allied Sci. 2024;4(2):1-4. doi:10.51847/WXAMJiBFbr
  39. Nasim MJ, Zuraik MM, Abdin AY, Ney Y, Jacob C. Selenomethionine: a pink Trojan redox horse with implications in aging and various age-related diseases. Antioxidants (Basel). 2021;10(6):882. doi:10.3390/antiox10060882
  40. Sun J, Xie X, Song Y, Sun T, Liu X, Yuan H, et al. Selenomethionine in gelatin methacryloyl hydrogels: modulating ferroptosis to attenuate skin aging. Bioact Mater. 2024;35:495-516. doi:10.1016/j.bioactmat.2024.02.013
  41. Dipalma G, Inchingolo AD, Fiore A, Balestriere L, Nardelli P, Casamassima L, et al. Comparative effects of fixed and clear aligner therapy on oral microbiome dynamics. Asian J Periodontics Orthod. 2022;2:33-41. doi:10.51847/mK28wdKCIX
  42. Sun H, Zhao L, Xu ZJ, De Marco M, Briens M, Yan XH, et al. Hydroxy-Selenomethionine improves the Selenium status and helps to maintain broiler performance under a high stocking density and heat stress conditions through a better redox and immune response. Antioxidants (Basel). 2021;10(10):1542. doi:10.3390/antiox10101542
  43. Wang X, Wu B, Sun G, Gao J, Huang T, Liu J, et al. Dietary selenomethionine attenuates obesity by enhancing beiging process in white adipose tissue. J Nutr Biochem. 2023;113:109230. doi:10.1016/j.jnutbio.2022.109230
  44. Pisano M, Sangiovanni G, Frucci E, Scorziello M, Benedetto GD, Iandolo A. Assessing the reliability of electronic apex locators in different apical foramen configurations. Asian J Periodontics Orthod. 2023;3:1-5. doi:10.51847/qOUk0OkkRZ
  45. Minich WB. Selenium metabolism and biosynthesis of selenoproteins in the human body. Biochemistry (Mosc). 2022;87(Suppl 1):S168-S102. doi:10.1134/S0006297922140139
  46. Niu R, Yang Q, Dong Y, Hou Y, Liu G. Selenium metabolism and regulation of immune cells in immune-associated diseases. J Cell Physiol. 2022;237(9):3449-64. doi:10.1002/jcp.30824
  47. Zhang F, Li X, Wei Y. Selenium and selenoproteins in health. Biomolecules. 2023;13(5):799. doi:10.3390/biom13050799
  48. Makhoahle P, Gaseitsiwe T. Efficacy of disinfectants on common laboratory surface microorganisms at R.S Mangaliso hospital, NHLS laboratory, South Africa. Bull Pioneer Res Med Clin Sci. 2022;1(1):1-12. doi:10.51847/d5bXpXAtcI 
  49. Huang Z, Rose AH, Hoffmann PR. The role of Selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2012;16(7):705-43. doi:10.1089/ars.2011.4145
  50. Bolay Ş, Öztürk E, Tuncel B, Ertan A. Studying fracture strength of root-treated and reconstructed teeth with two types of post and core. Ann J Dent Med Assist. 2024;4(2):1-6. doi:10.51847/i57dzmzc2A
  51. Vinceti M, Filippini T, Rothman KJ. Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):789-810. doi:10.1007/s10654-018-0422-8
  52. Graefen B, Hasanli S, Fazal N. Behind the white coat: the prevalence of burnout among obstetrics and gynecology residents in Azerbaijan. Bull Pioneer Res Med Clin Sci. 2023;2(2):1-7. doi:10.51847/vIIhM1UG2l
  53. Dhanasekar P, Rajayyan JS, Veerabadiran Y, Kumar KS, Kumar KS, Chinnadurai N. Evaluation of alum and purification process of water by coagulation method. Bull Pioneer Res Med Clin Sci. 2022;1(2):1-6. doi:10.51847/R8GyfOmMDh
  54. Avery JC, Hoffmann PR. Selenium, selenoproteins, and immunity. Nutrients. 2018;10(9):1203. doi:10.3390/nu10091203
  55. Bulusu A, Cleary SD. Comparison of dental caries in autistic children with healthy children. Ann J Dent Med Assist. 2023;3(2):14-9. doi:10.51847/wa2pZXE4RJ
  56. Hu Y, Liu T, Li J, Mai F, Li J, Chen Y, et al. Selenium nanoparticles as new strategy to potentiate γδ T cell antitumor cytotoxicity through upregulation of tubulin-α acetylation. Biomaterials. 2019;222:119397. doi:10.1016/j.biomaterials.2019.119397
  57. Verevkina M, Gasparian I, Ermakov M, Kozlikin A, Pavlenko E, Pavlenko A, et al. Milk fortification with a complex of iron with Ascorbic Acid for control of Iron deficiency Anemia. J Adv Pharm Educ Res. 2024;14(1):77-83. doi:10.51847/iNNlmykxn5
  58. Shih CW, Chen YJ, Chen WL. Inverse association between serum Selenium level and severity of liver fibrosis: a cross-sectional study. Nutrients. 2022;14(17):3625. doi:10.3390/nu14173625
  59. Malcangi G, Patano A, Trilli I, Piras F, Ciocia AM, Inchingolo AD, et al. A systematic review of the role of soft tissue lasers in enhancing esthetic dental procedures. Int J Dent Res Allied Sci. 2023;3(2):1-8. doi:10.51847/DWXltUS9Lp
  60. Rayman MP, Winther KH, Pastor-Barriuso R, Cold F, Thvilum M, Stranges S, et al. Effect of long-term Selenium supplementation on mortality: results from a multiple-dose, randomised controlled trial. Free Radic Biol Med. 2018;127:46-54. doi:10.1016/j.freeradbiomed.2018.02.015
  61. AlHussain BS, AlFayez AA, AlDuhaymi AA, AlMulhim EA, Assiri MY, Ansari SH. Impact of different antibacterial substances in dental composite materials: a comprehensive review. Int J Dent Res Allied Sci. 2022;2(1):1-7. doi:10.51847/jg2xu2PbJK
  62. Winther KH, Rayman MP, Bonnema SJ, Hegedüs L. Selenium in thyroid disorders - essential knowledge for clinicians. Nat Rev Endocrinol. 2020;16(3):165-76. doi:10.1038/s41574-019-0311-6
  63. Maneea ASB, Alqahtani AD, Alhazzaa AK, Albalawi AO, Alotaibi AK, Alanazi TF. Systematic review of the microbiological impact of Sodium hypochlorite concentrations in endodontic treatment. Int J Dent Res Allied Sci. 2024;4(2):9-15. doi:10.51847/PH80PpWOX7
  64. Perri G, Hill TR, Mathers JC, Walsh JS, Gossiel F, Winther K, et al. Long-term Selenium-yeast supplementation does not affect bone turnover markers: a randomized placebo-controlled trial. J Bone Miner Res. 2022;37(11):2165-73. doi:10.1002/jbmr.4703
  65. Goldson AJ, Fairweather-Tait SJ, Armah CN, Bao Y, Broadley MR, Dainty JR, et al. Effects of Selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial. PLoS One. 2011;6(3):e14771. doi:10.1371/journal.pone.0014771
  66. Shaheen RS, Alsaffan AD, Al-Dusari RS, Helmi RN, Baseer MA. Self-reported oral hygiene and gum health among dental and medical students, dentists, and physicians in Saudi Arabia. Turk J Public Health Dent. 2023;3(1):9-16. doi:10.51847/SZCGti8lFn
  67. Fernandes AL, Malik JB, Ansari SR, Murali S, Thirupathii J. Saudi dentists' knowledge and approaches to managing tooth wear: a cross-sectional survey-based analysis. Turk J Public Health Dent. 2022;2(2):1-12. doi:10.51847/p7ulFD4XZm
  68. Ravoori S, Sekhar PR, Pachava S, Pavani NPM, Shaik PS, Ramanarayana B. Perceived stress and depression among oral cancer patients - a hospital-based cross-sectional study. Turk J Public Health Dent. 2024;4(1):1-5. doi:10.51847/FoK9xAl1JW

 

 

 


How to cite this article:
Vancouver
Kravchenko DS, Vendina DA, Uzdenova BA, Vykhovanets LK, Chernyadeva AV, Akilaeva AM, et al. Selenomethionine in the correction of selenium deficiency: effects on oxidative stress and immune status. J Adv Pharm Educ Res. 2025;15(2):171-9. https://doi.org/10.51847/pIjEbpuMgw
APA
Kravchenko, D. S., Vendina, D. A., Uzdenova, B. A., Vykhovanets, L. K., Chernyadeva, A. V., Akilaeva, A. M., Ponomareva, M. A., & Kuznetsova, N. G. (2025). Selenomethionine in the correction of selenium deficiency: effects on oxidative stress and immune status. Journal of Advanced Pharmacy Education and Research, 15(2), 171-179. https://doi.org/10.51847/pIjEbpuMgw
Citation Formats:

Most viewed articles:


Contact Meral


Meral Publications
www.meralpublisher.com

Davutpasa / Zeytinburnu 34087
Istanbul
Turkey

Email: [email protected]